Systematic review finds limited but promising evidence for cannabis in fibromyalgia | Research

The takeaway

Across four RCTs and five observational studies totaling 564 patients, cannabis showed low-quality evidence of short-term pain reduction in fibromyalgia, with only one RCT finding no difference from placebo.

Fibromyalgia patients, pain medicine clinicians, and researchers designing future cannabis-fibromyalgia trials.

3 of 4 RCTs showed cannabis outperformed placebo for fibromyalgia pain

What the researchers found

Of four RCTs examining cannabis for fibromyalgia, three showed benefit over placebo for pain. Observational studies supported these findings. However, evidence quality was low and studies were small.

Why it matters

Fibromyalgia affects millions and current treatments often fall short. This systematic review provides the most structured look at whether cannabis could fill that gap, even if the evidence base remains thin.

The numbers in context

564 total patients across 9 studies (4 RCTs, 5 observational). Three of four RCTs showed cannabis outperformed placebo for pain outcomes. Literature searched through October 2022.

How the study worked

Systematic review following PRISMA guidelines. Searched MEDLINE, EMBASE, Cochrane, and Scopus using MeSH terms. Included four RCTs and five observational studies totaling 564 patients.

What this study cannot tell us

Low overall evidence quality. Small sample sizes across studies. Heterogeneous cannabis preparations and dosing. Short study durations. Observational studies prone to expectation bias.

How to read the evidence

Systematic review with multiple RCTs, though small sample sizes and low evidence quality limit the strength of conclusions.

When this study was published

Published 2023. Literature search through October 2022.

The bigger picture

Many fibromyalgia patients already use cannabis, often without clinical guidance. Building a proper evidence base requires larger, longer RCTs with standardized cannabis formulations and consistent outcome measures.

Questions still open

Which cannabinoid profiles work best for fibromyalgia? Do benefits persist beyond the short-term windows studied? How does cannabis compare to approved fibromyalgia medications head-to-head?

Common questions

Does cannabis help fibromyalgia?

The evidence is promising but weak. Three of four randomized controlled trials found cannabis reduced pain more than placebo, but studies were small and short-term. The systematic review rates the overall evidence as low quality.

Is cannabis safe for fibromyalgia patients?

The review describes cannabis as appearing safe in the short term for fibromyalgia patients, but long-term safety data is lacking. Side effects in the included studies were generally mild.

Read the original research

Cannabis for the Treatment of Fibromyalgia: A Systematic Review.

Biomedicines, 11(6)

View on PubMed ↗Publisher’s paper ↗

Citation

Strand, Natalie H; Maloney, Jillian; Kraus, Molly; Wie, Christopher; Turkiewicz, Michal; Gomez, Diego A; Adeleye, Olufunmilola; Harbell, Monica W. (2023). Cannabis for the Treatment of Fibromyalgia: A Systematic Review.. Biomedicines, 11(6). https://doi.org/10.3390/biomedicines11061621